Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07246499

Multicentre Study on the Impact of Transmucosal Abutment Surface Characteristics on Peri-implant Tissues.

Characteristics of Transmucosal Abutments for Dental Implants.

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
25 (estimated)
Sponsor
University of Valencia · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The main objective of the study is to perform proteomic adsorption analysis on machined (grey) and anodised (pink) surfaces and compared them. The aim is to evaluate the regenerative potential involving improvement in the healing of peri-implant soft tissues in patients with dental implants. This surgery is indicated in healthy patients when they lost their teeth. The main question it seeks to answer is: \- In dental abutments, is anodised surface more effective than machined surface in terms of the degree of healing? The study will include patients who need this type of surgery and meet specific clinical criteria. Each patient will have one of the two dental abutments applied as part of the standard surgical procedure. Subsequently, participants will undergo clinical and proteomic follow-up assessments to evaluate the progress and extent of peri-implant tissue healing over a three-months period.

Conditions

Interventions

TypeNameDescription
DEVICEPink anodized implant abutment.Participants will receive a pink anodized titanium implant abutment placed during the surgical and osseointegrated phase of treatment. Peri-implant tissue healing will be assessed over a three-month follow-up period through clinical examination and proteomic analysis.
DEVICEGrey machined implant abutment.Participants will receive a grey machined titanium implant abutment placed during the surgical and osseointegrated phase of treatment. Peri-implant tissue healing will be assessed over a three-month follow-up period through clinical examination and proteomic analysis.

Timeline

Start date
2025-11-01
Primary completion
2026-03-01
Completion
2026-06-01
First posted
2025-11-24
Last updated
2025-11-24

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT07246499. Inclusion in this directory is not an endorsement.